Delivery Order SPE2DR25D3103-SPE2DR26F9S08
- Not listed
- The Defense Logistics Agency awarded a $12,987.74 delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Trelegy Ellipta 100-62.5-25 (a combination respiratory medication) in a 60-dose configuration. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract carries no...
- The Defense Logistics Agency awarded a $7,508.38 delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Trelegy Ellipta 200-62.5-25 (a combination respiratory medication), with an ultimate completion date of November 7, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Trelegy Ellipta 100-62.5-25 (a combination respiratory medication), with a ceiling value of $1,341.93 and an ultimate completion date of December 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $15,243.87 delivery order to AmerisourceBergen Drug Corp on September 27, 2025, for the supply of Trelegy Ellipta 100-62.5-25 (a combination respiratory medication) in a 60-dose configuration. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order as...
- The Defense Logistics Agency awarded a $2,837.16 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Trelegy Ellipta 100-62.5-25 (a combination pulmonary medication) in a 60-dose configuration. This firm fixed-price delivery order, which carries an ultimate completion date of December 10, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $8,492.56 to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Trelegy Ellipta 200-62.5-25, a combination respiratory medication, with an ultimate completion date of November 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,013.53 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 60S, a combination respiratory medication used to treat chronic obstructive pulmonary disease. The order was issued on December 22, 2025, with an ultimate completion date of December 23, 2025, under a firm fixed-price contract type with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $50,724.85 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Trelegy Ellipta 100-62.5-25, a combination inhalation powder medication used in respiratory disease treatment. This firm fixed-price delivery order, which is not set-aside designated, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,172.61 to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This firm fixed-price delivery order, with an ultimate completion date of December 16, 2025, was competitively awarded with no set-aside designation. The contractor, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,211.94 to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of December 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9S08Delivery Order
The Defense Logistics Agency awarded a $10,943.18 delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Trelegy Ellipta 100-62.5-25 (a combination respiratory medication) in a 60-dose configuration. This non-set-aside, competitively awarded contract carries firm fixed pricing and is scheduled for completion by December 23, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle provides comprehensive pharmaceutical and medical supply support to military healthcare programs worldwide, covering specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The contract supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems as part of DLA's broader strategy to ensure pharmaceutical supply chain resilience for federal medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 12/21/25 |